Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
SBRT + Atezolizumab + Bevacizumab for Liver Cancer
Recruiting1 awardPhase < 1
Boston, Massachusetts
This trial is looking at how well neoadjuvant SBRT (a type of radiation therapy) with atezolizumab and bevacizumab (two cancer-fighting drugs) work in treating resectable hepatocellular carcinoma (a type of liver cancer). Researchers want to see if this neoadjuvant therapy combination is safe and tolerable.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.